Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EIPICO | Egypt | Healthcare | Pharmaceuticals | EGP 7B | 6.4x | EGP 47.20 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Tenth of Ramadan | Egypt | Healthcare | Pharmaceuticals | EGP 4.19B | 18.5x | 12.42 | EGP 2.78 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.8% Upside | Upgrade to Pro+ | |
Glaxo Smith Kline | Egypt | Healthcare | Pharmaceuticals | EGP 3.21B | 24.1x | 0.11 | EGP 37.88 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Minapharm Pharma | Egypt | Healthcare | Pharmaceuticals | EGP 1.70B | -6.3x | 0.04 | EGP 155.69 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
October Pharma | Egypt | Healthcare | Pharmaceuticals | EGP 1.52B | 11.1x | EGP 123.42 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kahira Pharmaceuticals and Chemical Industries | Egypt | Healthcare | Pharmaceuticals | EGP 1.23B | 5.3x | 0.02 | EGP 82.50 | 9.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alexandria Pharma | Egypt | Healthcare | Pharmaceuticals | EGP 1.17B | 5.6x | EGP 239.99 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Macro Pharmaceutical | Egypt | Healthcare | Pharmaceuticals | EGP 1.02B | -2.5x | 0.01 | EGP 1.84 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nile Pharma | Egypt | Healthcare | Pharmaceuticals | EGP 749.25M | 4.6x | EGP 74 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Arab Pharma | Egypt | Healthcare | Pharmaceuticals | EGP 570M | 6.4x | 0.26 | EGP 95 | 9.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sabaa Intl Pharma and Chemical Industries | Egypt | Healthcare | Pharmaceuticals | EGP 226.50M | -34.8x | -4.33 | EGP 0.91 | 20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Memphis Pharma | Egypt | Healthcare | Pharmaceuticals | EGP 212.62M | 1.1x | EGP 37.79 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |